FDA Inspection 1233993 — Merck Kommanditgesellschaft auf Aktien

Merck Kommanditgesellschaft auf Aktien — FEI 3002806906

The FDA completed an inspection of Merck Kommanditgesellschaft auf Aktien on July 19, 2024 in Darmstadt. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Darmstadt (Germany)